Time Course and Role of Exercise-Induced Cytokines in Muscle Damage and Repair After a Marathon Race
Open Access
- 15 October 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 12
Abstract
Endurance exercise induces an increase in the expression of exercise-induced peptides that participate in the repair and regeneration of skeletal muscles. The present study aimed to evaluate the time course and role of exercise-induced cytokines in muscle damage and repair after a marathon race. Fifty-seven Brazilian male amateur marathon finishers, aged 30–55 years, participated in this study. The blood samples were collected 24 h before, immediately after, and 24 and 72 h after the São Paulo International Marathon. The leukogram and muscle damage markers were analyzed using routine automated methodology in the clinical laboratory. The plasma levels of the exercise-induced cytokines were determined using the Human Magnetic Bead Panel or enzyme-linked immunosorbent assays [decorin and growth differentiation factor 15 (GDF-15)]. A muscle damage was characterized by an increase in plasma myocellular proteins and immune changes (leukocytosis and neutrophilia). Running the marathon increased interleukin (IL)-6 (4-fold), IL-8 (1.5-fold), monocyte chemoattractant protein-1 (2.4-fold), tumor necrosis factor alpha (TNF-α) (1.5-fold), IL-10 (11-fold), decorin (1.9-fold), GDF-15 (1.8-fold), brain-derived neurotrophic factor (BDNF) (2.7-fold), follistatin (2-fold), and fibroblast growth factor (FGF-21) (3.4-fold) plasma levels. We also observed a reduction in musclin, myostatin, IL-15, and apelin levels immediately after the race (by 22–36%), 24 h (by 26–52%), and 72 h after the race (by 25–53%). The changes in BDNF levels were negatively correlated with the variations in troponin levels (r = −0.36). The variations in IL-6 concentrations were correlated with the changes in follistatin (r = 0.33) and FGF-21 (r = 0.31) levels after the race and with myostatin and irisin levels 72 h after the race. The changes in IL-8 and IL-10 levels had positive correlation with variation in musclin (p < 0.05). Regeneration of exercise-induced muscle damage involves the participation of classical inflammatory mediators, as well as GDF-15, BDNF, follistatin, decorin, and FGF-21, whose functions include myogenesis, mytophagia, satellite cell activation, and downregulation of protein degradation. The skeletal muscle damage markers were not associated to myokines response. However, BDNF had a negative correlation with a myocardial damage marker. The classical anti-inflammatory mediators (IL-10, IL-8, and IL-6) induced by exercise are associated to myokines response immediately after the race and in the recovery period and may affect the dynamics of muscle tissue repair.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo
This publication has 40 references indexed in Scilit:
- Acute exercise increases fibroblast growth factor 21 in metabolic organs and circulationPhysiological Reports, 2016
- Inhibition of the myostatin/Smad signaling pathway by short decorin-derived peptidesExperimental Cell Research, 2016
- Musclin is an activity-stimulated myokine that enhances physical enduranceProceedings of the National Academy of Sciences, 2015
- Cytokine expression and secretion by skeletal muscle cells: regulatory mechanisms and exercise effects.2015
- Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatinJournal of Cell Biology, 2012
- IL-6 selectively stimulates fat metabolism in human skeletal muscleAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- Interleukin-6 Is an Essential Regulator of Satellite Cell-Mediated Skeletal Muscle HypertrophyCell Metabolism, 2008
- Decorin Gene Transfer Promotes Muscle Cell Differentiation and Muscle RegenerationMolecular Therapy, 2007
- Interleukin-6 Increases Insulin-Stimulated Glucose Disposal in Humans and Glucose Uptake and Fatty Acid Oxidation In Vitro via AMP-Activated Protein KinaseDiabetes, 2006
- Muscle‐derived interleukin‐6: possible biological effectsThe Journal of Physiology, 2001